JPRN-UMIN000008097已完成1 期
Combination of chemotherapy with docetaxel / cisplatin / fluorouracil (DCF) and autologous gamma/delta T cell transfer therapy for esophageal cancer. - DCF and gamma/delta T cell therapy for esophageal cancer.
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who have: -Pulmonary fibrosis or interstitial pneumonia, including their history or predisposition; -Treated with chemoradiotherapy; -Active enteritis; -Active autoimmune diseases, -Active infections; -Other cancers; -Other serious complications; -Continuous systemic administration of steroids.
研究者
相似试验
未知
1 期
Combination chemotherapy with docetaxel, cisplatine, and 5-fluorouracil for patients with advanced head and neck cancer: a phase I/II trialSquamous cell carcinoma of the head and neckJPRN-UMIN000000744Department of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine, University of Yamanashi53
进行中（未招募）
2 期
Induction chemotherapy for HPV positive oropharyngeal cancers (HIPPOCRATES)Human papillomavirus-associated oropharyngeal cancersHuman papillomavirus, oropharyngeal cancersJPRN-jRCT1041220029Yokota Tomoya30
已完成
不适用
Adjuvant chemotherapy combined with docetaxel and cyclophosphamide for Japanese breast cancer patients without lymph node metastasis or with three and under lymph node metastasis.Breast cancerJPRN-UMIN000002310Gunma Breast Cancer Research Group 2 surgery90
进行中（未招募）
不适用
Induction chemotherapy with docetaxel and cisplatin followed by radiotherapy concomitant with cetuximab for locally advanced stage III non-small cell lung cancer- amulticentre, open label non-randomised phase II trial - SatellitPatient with locally advanced stage III non-small cell lung cancer.EUCTR2005-003867-21-SESahlgrenska University Hospital75
已完成
2 期
Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by chemoradiotherapy concurrent with fractionated administration of high-dose cisplatin for patients with locally advanced squamous cell carcinoma of the head and neckocally advanced head and neck cancerJPRN-UMIN000024686ational Cancer Center Hospital East48